Definitive Healthcare Corp
NASDAQ:DH

  • LAST PRICE
    4.7300
  • TODAY'S CHANGE (%)
    0.0700 (1.5021%)
  • Bid / Lots
    4.7000/ 2
  • Ask / Lots
    4.9600/ 3
  • Open / Previous Close
    4.6800 / 4.6600
  • Day Range
    4.6500
    4.7900
  • 52 Week Range
    3.1900
    10.6200
  • Volume
    150,049

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 7, 2024

      Show headlines and story abstract

    • 4:25PM ET on Thursday Nov 07, 2024 by MT Newswires
      Companies Mentioned: DH
      04:25 PM EST, 11/07/2024 (MT Newswires) -- ...

    • 4:25PM ET on Thursday Nov 07, 2024 by MT Newswires
      Companies Mentioned: DH
      04:25 PM EST, 11/07/2024 (MT Newswires) -- ...

    • 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
      Companies Mentioned: DH
      Income $ 15,393 $ 14,576 $ 42,590 $ 36,044 ----------- ----------- ----------- ----------- Shares for Adjusted Net Income Per Diluted Share (a) 155,519,356 154,970,793 156,339,848 154,592,703 Adjusted Net Income Per Share $ 0.10 $ 0.09 $ 0.27 $ 0.23 (a) Diluted Adjusted Net Income Per Share is computed by giving effect to all potential weighted average Class A common stock and any securities that are convertible into Class A common stock, including Definitive OpCo units and restricted stock units. The dilutive effect of outstanding awards and convertible securities is reflected in diluted earnings per share by application of the treasury stock method assuming proceeds from unrecognized compensation as required by GAAP. Fully diluted shares are 163,996,756 and 162,910,958 as of September 30, 2024 and 2023, respectively. Reconciliation of GAAP Gross Profit and Margin to Adjusted Gross Profit and Margin (in thousands, except percentages; unaudited) Three Months Ended September 30, Nine Months Ended September 30, -------------------------------------- ------------------------------------------- 2024 2023 2024 2023 ------------- ------------- -------------- ------------- ------ % of % of % of (in thousands) Amount Revenue Amount Revenue Amount Revenue Amount % of Revenue ------- --------- ------- --------- -------- --------- -------- ------------ Reported gross profit and margin $49,031 78% $53,430 82% $149,867 79% $150,514 81% Amortization of intangible assets acquired through business combinations 2,573 4% 2,303 4% 7,383 4% 6,907 4% Equity compensation costs 88 0% 276 0% 668 0% 830 0% ------ ------ ------- ------- Adjusted gross profit and margin $51,692 82% $56,009 86% $157,918 83% $158,251 85% ====== ===== ====== ===== ======= ===== ======= ==== ===== Reconciliation of GAAP Net Loss to Adjusted EBITDA (in thousands, except percentages; unaudited) Three Months Ended September 30, Nine Months Ended September 30, ---------------------------------------------------- --------------------------------------------- 2024 2023 2024 2023 -------------------- -------------------- ---------------- --------------- ---- % of % of Amount % of Revenue Amount % of Revenue Amount Revenue Amount Revenue ---------- ------------- ---------- ------------- ---------- --------- ---------- ---------- Net loss and margin $(187,824) (300)% $(248,688) (381)% $(506,729) (267)% $(276,265) (149)% Interest expense (income), net 7 0% 433 1% (58) (0)% 1,434 1% Benefit from income taxes (13,724) (22)% (17,534) (27)% (36,404) (19)% (19,728) (11)% Depreciation & amortization 13,063 21% 13,027 20% 38,535 20% 38,749 21% -------- ----- -------- ----- -------- ----- -------- ---- --- EBITDA and margin (188,478) (301)% (252,762) (387)% (504,656) (266)% (255,810) (138)% Other income, net (a) (23,826) (38)% (29,589) (45)% (68,066) (36)% (25,161) (14)% Equity-based compensation (b) 6,296 10% 11,994 18% 30,720 16% 35,485 19% Transaction, integration, and restructuring expenses (c) (1,995) (3)% 3,505 5% 9,390 5% 9,666 5% Goodwill impairment (d) 228,153 364% 287,400 440% 591,794 312% 287,400 155% Other non-core items (e) 465 1% 1,196 2% 2,375 1% 3,072 2% -------- ----- -------- ----- -------- ----- -------- ---- --- Adjusted EBITDA and margin $ 20,615 33% $ 21,744 33% $ 61,557 32% $ 54,652 29% (a) Primarily represents foreign exchange and TRA liability remeasurement gains and losses. (b) Equity-based compensation represents non-cash compensation expense recognized in association with equity awards made to employees and directors. (c) Transaction and integration expenses primarily represent legal, accounting, and consulting expenses and fair value adjustments for contingent consideration related to our acquisitions. Restructuring expenses relate to the 2024 Restructuring Plan and those we committed to during the first and third quarters of 2023, as well as impairment and restructuring charges related to office closures, relocations, and consolidations. Three Months Ended Nine Months Ended September 30, September 30, ------------------------- ------------------------- (in thousands) 2024 2023 2024 2023 -------- ----- -------- ----- Merger and acquisition due diligence and transaction costs $ 1,114 $ 1,033 $ 2,410 $ 4,110 Integration costs 211 474 939 805 Fair value adjustment for contingent consideration (3,510) -- (3,240) -- Restructuring charges for severance and other separation costs 190 2,141 8,009 4,596 Office closure and relocation restructuring charges and impairments -- (143) 1,272 155 Total transaction, integration and restructuring expenses $ (1,995) $ 3,505 $ 9,390 $ 9,666 ======== ===== ======== =====

    • 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
      Companies Mentioned: DH
      Income $ 15,393 $ 14,576 $ 42,590 $ 36,044 ----------- ----------- ----------- ----------- Shares for Adjusted Net Income Per Diluted Share (a) 155,519,356 154,970,793 156,339,848 154,592,703 Adjusted Net Income Per Share $ 0.10 $ 0.09 $ 0.27 $ 0.23 (a) Diluted Adjusted Net Income Per Share is computed by giving effect to all potential weighted average Class A common stock and any securities that are convertible into Class A common stock, including Definitive OpCo units and restricted stock units. The dilutive effect of outstanding awards and convertible securities is reflected in diluted earnings per share by application of the treasury stock method assuming proceeds from unrecognized compensation as required by GAAP. Fully diluted shares are 163,996,756 and 162,910,958 as of September 30, 2024 and 2023, respectively. Reconciliation of GAAP Gross Profit and Margin to Adjusted Gross Profit and Margin (in thousands, except percentages; unaudited) Three Months Ended September 30, Nine Months Ended September 30, -------------------------------------- ------------------------------------------- 2024 2023 2024 2023 ------------- ------------- -------------- ------------- ------ % of % of % of (in thousands) Amount Revenue Amount Revenue Amount Revenue Amount % of Revenue ------- --------- ------- --------- -------- --------- -------- ------------ Reported gross profit and margin $49,031 78% $53,430 82% $149,867 79% $150,514 81% Amortization of intangible assets acquired through business combinations 2,573 4% 2,303 4% 7,383 4% 6,907 4% Equity compensation costs 88 0% 276 0% 668 0% 830 0% ------ ------ ------- ------- Adjusted gross profit and margin $51,692 82% $56,009 86% $157,918 83% $158,251 85% ====== ===== ====== ===== ======= ===== ======= ==== ===== Reconciliation of GAAP Net Loss to Adjusted EBITDA (in thousands, except percentages; unaudited) Three Months Ended September 30, Nine Months Ended September 30, ---------------------------------------------------- --------------------------------------------- 2024 2023 2024 2023 -------------------- -------------------- ---------------- --------------- ---- % of % of Amount % of Revenue Amount % of Revenue Amount Revenue Amount Revenue ---------- ------------- ---------- ------------- ---------- --------- ---------- ---------- Net loss and margin $(187,824) (300)% $(248,688) (381)% $(506,729) (267)% $(276,265) (149)% Interest expense (income), net 7 0% 433 1% (58) (0)% 1,434 1% Benefit from income taxes (13,724) (22)% (17,534) (27)% (36,404) (19)% (19,728) (11)% Depreciation & amortization 13,063 21% 13,027 20% 38,535 20% 38,749 21% -------- ----- -------- ----- -------- ----- -------- ---- --- EBITDA and margin (188,478) (301)% (252,762) (387)% (504,656) (266)% (255,810) (138)% Other income, net (a) (23,826) (38)% (29,589) (45)% (68,066) (36)% (25,161) (14)% Equity-based compensation (b) 6,296 10% 11,994 18% 30,720 16% 35,485 19% Transaction, integration, and restructuring expenses (c) (1,995) (3)% 3,505 5% 9,390 5% 9,666 5% Goodwill impairment (d) 228,153 364% 287,400 440% 591,794 312% 287,400 155% Other non-core items (e) 465 1% 1,196 2% 2,375 1% 3,072 2% -------- ----- -------- ----- -------- ----- -------- ---- --- Adjusted EBITDA and margin $ 20,615 33% $ 21,744 33% $ 61,557 32% $ 54,652 29% (a) Primarily represents foreign exchange and TRA liability remeasurement gains and losses. (b) Equity-based compensation represents non-cash compensation expense recognized in association with equity awards made to employees and directors. (c) Transaction and integration expenses primarily represent legal, accounting, and consulting expenses and fair value adjustments for contingent consideration related to our acquisitions. Restructuring expenses relate to the 2024 Restructuring Plan and those we committed to during the first and third quarters of 2023, as well as impairment and restructuring charges related to office closures, relocations, and consolidations. Three Months Ended Nine Months Ended September 30, September 30, ------------------------- ------------------------- (in thousands) 2024 2023 2024 2023 -------- ----- -------- ----- Merger and acquisition due diligence and transaction costs $ 1,114 $ 1,033 $ 2,410 $ 4,110 Integration costs 211 474 939 805 Fair value adjustment for contingent consideration (3,510) -- (3,240) -- Restructuring charges for severance and other separation costs 190 2,141 8,009 4,596 Office closure and relocation restructuring charges and impairments -- (143) 1,272 155 Total transaction, integration and restructuring expenses $ (1,995) $ 3,505 $ 9,390 $ 9,666 ======== ===== ======== =====

Peers Headlines